Health

FDA OKs New COVID-19 Saliva Tests

The Food and Drug Administration has given its approval for an inexpensive, faster saliva-based coronavirus test.

The FDA gave emergency-use authorization for the test, SalivaDirect, which was developed by researchers at Yale University.

The test is currently used by the NBA to check asymptomatic players and staff and has received partial funding from the league and the NBA Players Association, AL.com reported. Labs are expected to charge about $10 per test, with a turnaround time for results of about three hours.

Researchers said the test is less invasive than the more common nasopharyngeal swab.

The test could be available to the general public in a few weeks, AL.com reported.

Tags
Show More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *


By submitting this form, you are consenting to receive marketing emails from: Washington Informer Newspaper, 3117 Martin Luther King Jr. Ave SE, Washington, DC, 20032, http://www.washingtoninformer.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Back to top button

My News Matters to me - Washington Informer Donations

Be a Part of The Washington Informer Legacy

A donation of your choice empowers our journalists to continue the work to better inform, educate and empower you through technology and resources that you use.

Click Here Today to Support Black Press and be a part of the Legacy!

Subscribe today for free and be the first to have news and information delivered directly to your inbox.


By submitting this form, you are consenting to receive marketing emails from: Washington Informer Newspaper, 3117 Martin Luther King Jr. Ave SE, Washington, DC, 20032, http://www.washingtoninformer.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact
Close

Adblock Detected

Please consider supporting us by disabling your ad blocker